Optimized induction of beta common receptor enhances the neuroprotective function of erythropoietin in spinal cord ischemic injury

Journal of Thoracic and Cardiovascular Surgery

Volumn 155, Issue 6, 2018, Pages 2505-2516

  Yamanaka, Katsuhiro ^a   Eldeiry, Mohamed ^a   Aftab, Muhammad ^a   Mares, Joshua ^a   Ryan, Thomas J ^a   Meng, Xianzhong ^a   Weyant, Michael J ^a   Cleveland, Joseph C ^a   Fullerton, David A ^a   Reece, T Brett ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

ischemic reperfusion injury; spinal cord; thoracoabdominal aortic aneurysm

Indexed keywords

BETA COMMON RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIAZOXIDE; ERYTHROPOIETIN RECEPTOR; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; ERYTHROPOIETIN; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NONHUMAN; PARAPLEGIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SPINAL CORD ISCHEMIA; SURVIVAL; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD INJURY;

ANIMALS; DIAZOXIDE; ERYTHROPOIETIN; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD INJURIES; SPINAL CORD ISCHEMIA;

EID: 85042854204     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2017.12.132     Document Type: Article

References (27)

1. Masuda, M., Okumura, M., Doki, Y., Endo, S., Hirata, Y., Kobayashi, J., et al. Thoracic and cardiovascular surgery in Japan during 2014: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 64 (2016), 665–697.
2. Okita, Y., Fighting spinal cord complication during surgery for thoracoabdominal aortic disease. Gen Thorac Cardiovasc Surg 59 (2011), 79–90.
3. Nakagawa, I., Wajima, D., Tamura, K., Nishimura, F., Park, Y.S., Nakase, H., The neuroprotective effect of diazoxide is mediated by mitochondrial ATP-dependent potassium channels in a rat model of acute subdural hematoma. J Clin Neurosci 20 (2013), 144–147.
4. Smith, P.D., Puskas, F., Meng, X., Cho, D., Cleveland, J.C. Jr., Weyant, M.J., et al. Ischemic dose-response in the spinal cord: both immediate and delayed paraplegia. J Surg Res 174 (2012), 238–244.
5. Chateauvieux, S., Grigorakaki, C., Morceau, F., Dicato, M., Diederich, M., Erythropoietin, erythropoiesis and beyond. Biochem Pharmacol 82 (2011), 1291–1303.
6. Brines, M., Cerami, A., Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med 264 (2008), 405–432.
7. Mares, J.M., Foley, L.S., Bell, M.T., Bennett, D.T., Freeman, K.A., Meng, X., et al. Erythropoietin activates the phosporylated cAMP [adenosine 3′,5′-cyclic monophosphate] response element-binding protein pathway and attenuates delayed paraplegia after ischemia-reperfusion injury. J Thorac Cardiovasc Surg 149 (2015), 920–924.
8. Brines, M., Cerami, A., The receptor that tames the innate immune response. Mol Med 18 (2012), 486–496.
9. Wallach, I., Zhang, J., Hartmann, A., van Landeghem, F.K., Ivanova, A., Klar, M., et al. Erythropoietin-receptor gene regulation in neuronal cells. Pediatr Res 65 (2009), 619–624.
10. Foley, L.S., Fullerton, D.A., Bennett, D.T., Freeman, K.A., Mares, J., Bell, M.T., et al. Spinal cord ischemia-reperfusion injury induces erythropoietin receptor expression. Ann Thorac Surg 100 (2015), 41–46 discussion 46.
11. Basso, D.M., Fisher, L.C., Anderson, A.J., Jakeman, L.B., McTigue, D.M., Popovich, P.G., Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23 (2006), 635–659.
12. Crawford, E.S., Mizrahi, E.M., Hess, K.R., Coselli, J.S., Safi, H.J., Patel, V.M., The impact of distal aortic perfusion and somatosensory evoked potential monitoring on prevention of paraplegia after aortic aneurysm operation. J Thorac Cardiovasc Surg 95 (1988), 357–367.
13. Yamanaka, K., Sasaki, N., Fujita, Y., Kawamoto, A., Hirata, K., Okita, Y., Impact of acquired and innate immunity on spinal cord ischemia and reperfusion injury. Gen Thorac Cardiovasc Surg 64 (2016), 251–259.
14. Maniar, H.S., Sundt, T.M. III, Prasad, S.M., Chu, C.M., Camillo, C.J., Moon, M.R., et al. Delayed paraplegia after thoracic and thoracoabdominal aneurysm repair: a continuing risk. Ann Thorac Surg 75 (2003), 113–119 discussion 119-20.
15. Etz, C.D., Luehr, M., Kari, F.A., Bodian, C.A., Smego, D., Plestis, K.A., et al. Paraplegia after extensive thoracic and thoracoabdominal aortic aneurysm repair: does critical spinal cord ischemia occur postoperatively?. J Thorac Cardiovasc Surg 135 (2008), 324–330.
16. Bell, M.T., Reece, T.B., Smith, P.D., Mares, J., Weyant, M.J., Cleveland, J.C. Jr., et al. Reproducible paraplegia by thoracic aortic occlusion in a murine model of spinal cord ischemia-reperfusion. J Vis Exp, 85, 2014, 50910.
17. Smith, P.D., Puskas, F., Meng, X., Lee, J.H., Cleveland, J.C. Jr., Weyant, M.J., et al. The evolution of chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury. Circulation 126:11 Suppl 1 (2012), S110–S117.
18. Bell, M.T., Puskas, F., Agoston, V.A., Cleveland, J.C. Jr., Freeman, K.A., Gamboni, F., et al. Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury. Circulation 128:11 Suppl 1 (2013), S152–S156.
19. Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305 (2004), 239–242.
20. Jubinsky, P.T., Krijanovski, O.I., Nathan, D.G., Tavernier, J., Sieff, C.A., The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood 90 (1997), 1867–1873.
21. Smith, P.D., Puskas, F., Fullerton, D.A., Meng, X., Cho, D., Cleveland, J.C. Jr., et al. Attenuation of spinal cord ischemia and reperfusion injury by erythropoietin. J Thorac Cardiovasc Surg 141 (2011), 256–260.
22. Jung, J.E., Kim, G.S., Chen, H., Maier, C.M., Narasimhan, P., Song, Y.S., et al. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 41 (2010), 172–179.
23. Oshima, Y., Fujio, Y., Nakanishi, T., Itoh, N., Yamamoto, Y., Negoro, S., et al. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc Res 65 (2005), 428–435.
24. Bolli, R., Stein, A.B., Guo, Y., Wang, O.L., Rokosh, G., Dawn, B., et al. A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the up-regulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol 50 (2011), 589–597.
25. Fu, Z.Q., Shao, Q.L., Shen, J.L., Zhang, Y.J., Zhao, X.X., Yao, L., Effect of carbamylated erythropoietin on major histocompatibility complex expression and neural differentiation of human neural stem cells. J Neuroimmunol 221 (2010), 15–24.
26. Ehrenreich, H., Degner, D., Meller, J., Brines, M., Béhé, M., Hasselblatt, M., et al. Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry 9 (2004), 42–54.
27. Okita, Y., Surgery for thoracic aortic disease in Japan: evolving strategies toward the growing enemies. Gen Thorac Cardiovasc Surg 63 (2015), 185–196.